Prognostic value of histamine H1 receptor expression in oral squamous cell carcinoma

Clinical Oral Investigations

Volumn 17, Issue 3, 2013, Pages 949-955

  Grimm, Martin ^a   Krimmel, Michael ^a   Alexander, Dorothea ^a   Munz, Adelheid ^a   Kluba, Susanne ^a   Keutel, Constanze ^a   Hoffmann, Juergen ^a,b   Polligkeit, Joachim ^a   Reinert, Siegmar ^a   Hoefert, Sebastian ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Clinicopathological parameters; Histamine; Histamine 1 receptor; Oral squamous cell carcinoma; Prognostic factors

Indexed keywords

EID: 84884211475     PISSN: 14326981     EISSN: 14363771     Source Type: Journal    
DOI: 10.1007/s00784-012-0784-3     Document Type: Article

References (36)

1. Rivera ES, Cricco GP, Engel NI, Fitzsimons CP, Martin GA, Bergoc RM (2000) Histamine as an autocrine growth factor: an unusual role for a widespread mediator. Sem Cancer Biol 10(1): 15-23.
2. Kahlson G, Rosengren E (1968) New approaches to the physiology of histamine. Physiol Rev 48(1): 155-196.
3. Medina VA, Rivera ES (2010) Histamine receptors and cancer pharmacology. Br J Pharmacol 161(4): 755-767. doi: 10. 1111/j. 1476-5381. 2010. 00961. x.
4. Davio CA, Cricco GP, Bergoc RM, Rivera ES (1995) H1 and H2 histamine receptors in experimental carcinomas with an atypical coupling to signal transducers. Biochem Pharmacol 50(1): 91-96.
5. Bakker RA, Schoonus SBJ, Smit MJ, Timmerman H, Leurs R (2001) Histamine H1-receptor activation of nuclear factor-ΚB; roles for G gamma- and G alpha/11 subunits in constitutive and agonist-mediated signaling. Mol Pharmacol 60(5): 1133-1142.
6. Leurs R, Smit MJ, Timmerman H (1995) Molecular pharmacological aspects of histamine receptors. Pharmacol Ther 66(3): 413-463.
7. Mizuguchi H, Terao T, Kitai M, Ikeda M, Yoshimura Y, Das AK, Kitamura Y, Takeda N, Fukui H (2011) Involvement of protein kinase Cdelta/extracellular signal-regulated kinase/poly(ADP-ribose) polymerase-1 (PARP-1) signaling pathway in histamine-induced up-regulation of histamine H1 receptor gene expression in HeLa cells. J Biol Chem 286(35): 30542-30551. doi: 10. 1074/jbc. M111. 253104.
8. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5): 646-674. doi: 10. 1016/j. cell. 2011. 02. 013.
9. Jangi SM, Ruiz-Larrea MB, Nicolau-Galmes F, Andollo N, Arroyo-Berdugo Y, Ortega-Martinez I, Diaz-Perez JL, Boyano MD (2008) Terfenadine-induced apoptosis in human melanoma cells is mediated through Ca2+ homeostasis modulation and tyrosine kinase activity, independently of H1 histamine receptors. Carcinogenesis 29(3): 500-509. doi: 10. 1093/carcin/bgm292.
10. Jangi SM, Diaz-Perez JL, Ochoa-Lizarralde B, Martin-Ruiz I, Asumendi A, Perez-Yarza G, Gardeazabal J, Diaz-Ramon JL, Boyano MD (2006) H1 histamine receptor antagonists induce genotoxic and caspase-2-dependent apoptosis in human melanoma cells. Carcinogenesis 27(9): 1787-1796. doi: 10. 1093/carcin/bgl021.
11. Hadzijusufovic E, Peter B, Gleixner KV, Schuch K, Pickl WF, Thaiwong T, Yuzbasiyan-Gurkan V, Mirkina I, Willmann M, Valent P (2010) H1-receptor antagonists terfenadine and loratadine inhibit spontaneous growth of neoplastic mast cells. Exp Hematol 38(10): 896-907. doi: 10. 1016/j. exphem. 2010. 05. 008.
12. Pos Z, Wiener Z, Pocza P, Racz M, Toth S, Darvas Z, Molnar V, Hegyesi H, Falus A (2008) Histamine suppresses fibulin-5 and insulin-like growth factor-II receptor expression in melanoma. Cancer Res 68(6): 1997-2005. doi: 10. 1158/0008-5472. CAN-07-2816.
13. Soule BP, Simone NL, DeGraff WG, Choudhuri R, Cook JA, Mitchell JB (2010) Loratadine dysregulates cell cycle progression and enhances the effect of radiation in human tumor cell lines. Radiat Oncol 5: 8. doi: 10. 1186/1748-717X-5-8.
14. Nicolau-Galmes F, Asumendi A, Alonso-Tejerina E, Perez-Yarza G, Jangi SM, Gardeazabal J, Arroyo-Berdugo Y, Careaga JM, Diaz-Ramon JL, Apraiz A, Boyano MD (2011) Terfenadine induces apoptosis and autophagy in melanoma cells through ROS-dependent and -independent mechanisms. Apoptosis Int J Programmed Cell Death 16(12): 1253-1267. doi: 10. 1007/s10495-011-0640-y.
15. Blaya B, Nicolau-Galmes F, Jangi SM, Ortega-Martinez I, Alonso-Tejerina E, Burgos-Bretones J, Perez-Yarza G, Asumendi A, Boyano MD (2010) Histamine and histamine receptor antagonists in cancer biology. Inflamm Allergy Drug Targets 9(3): 146-157.
16. Jangi SM, Asumendi A, Arlucea J, Nieto N, Perez-Yarza G, Morales MC, de la Fuente-Pinedo M, Boyano MD (2004) Apoptosis of human T-cell acute lymphoblastic leukemia cells by diphenhydramine, an H1 histamine receptor antagonist. Oncol Res 14(7-8): 363-372.
17. Mao X, Liang SB, Hurren R, Gronda M, Chow S, Xu GW, Wang X, Beheshti Zavareh R, Jamal N, Messner H, Hedley DW, Datti A, Wrana JL, Zhu Y, Shi CX, Lee K, Tiedemann R, Trudel S, Stewart AK, Schimmer AD (2008) Cyproheptadine displays preclinical activity in myeloma and leukemia. Blood 112(3): 760-769. doi: 10. 1182/blood-2008-02-142687.
18. Liu JD, Wang YJ, Chen CH, Yu CF, Chen LC, Lin JK, Liang YC, Lin SY, Ho YS (2003) Molecular mechanisms of G0/G1 cell-cycle arrest and apoptosis induced by terfenadine in human cancer cells. Mol Carcinog 37(1): 39-50. doi: 10. 1002/mc. 10118.
19. Sobin LH, Ch W (2010) IUCC. TNM classification of malignant tumors, 7th edn. Springer, New York.
20. Hamilton SR, Aaltonen LA (2000) Pathology and genetics. Tumours of the digestive system, 3rd edn. IARC Press, Lyon.
21. von Rahden BH, Kircher S, Kafka M, Stuermer L, Reiber C, Gattenlohner S, Germer CT, Grimm M (2010) Glucocorticoid-induced TNFR family-related receptor (GITR)-expression in tumor infiltrating leucocytes (TILs) is associated with the pathogenesis of esophageal adenocarcinomas with and without Barrett's mucosa. Cancer Biomark 7(6): 285-294. doi: 10. 3233/CBM-2010-0192.
22. Grimm M, Lazariotou M, Kircher S, Hofelmayr A, Germer CT, von Rahden BH, Waaga-Gasser AM, Gasser M (2011) Tumor necrosis factor-alpha is associated with positive lymph node status in patients with recurrence of colorectal cancer-indications for anti-TNF-alpha agents in cancer treatment. Cell Oncol (Dordr). doi: 10. 1007/s13402-011-0027-7.
23. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 75: 457-487.
24. Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50(3): 163-170.
25. Cox DR (1972) Regression models and life tables. J R Stat Soc 34: 1987-2001.
26. Miyoshi K, Das AK, Fujimoto K, Horio S, Fukui H (2006) Recent advances in molecular pharmacology of the histamine systems: regulation of histamine H1 receptor signaling by changing its expression level. J Pharmacol Sci 101(1): 3-6.
27. Hegyesi H, Darvas Z, Laszlo V, Pos Z, Pallinger E, Hirschberg K, Kovacs P, Falus A (2004) Retinoic acid enhances histamine content and H1 receptor expression in human neuroblastoma cell line Paju. Anticancer Res 24(3a): 1657-1663.
28. Garcia-Caballero M, Neugebauer E, Rodriguez F, Nunez de Castro I, Vara-Thorbeck C (1994) Histamine synthesis and content in benign and malignant breast tumours. Its effects on other host tissues. Surg Oncol 3(3): 167-173.
29. Hegyesi H, Somlai B, Varga VL, Toth G, Kovacs P, Molnar EL, Laszlo V, Karpati S, Rivera E, Falus A, Darvas Z (2001) Suppression of melanoma cell proliferation by histidine decarboxylase specific antisense oligonucleotides. J Investig Dermatol 117(1): 151-153. doi: 10. 1046/j. 0022-202x. 2001. 01406. x.
30. Graff L, Frungieri M, Zanner R, Pohlinger A, Prinz C, Gratzl M (2002) Expression of histidine decarboxylase and synthesis of histamine by human small cell lung carcinoma. Am J Pathol 160(5): 1561-1565. doi: 10. 1016/S0002-9440(10)61102-9.
31. Garcia-Caballero M, Neugebauer E, Campos R, Nunez de Castro I, Vara-Thorbeck C (1988) Increased histidine decarboxylase (HDC) activity in human colorectal cancer: results of a study on ten patients. Agents Actions 23(3-4): 357-360.
32. Medina MA, Quesada AR, Nunez de Castro I, Sanchez-Jimenez F (1999) Histamine, polyamines, and cancer. Biochem Pharmacol 57(12): 1341-1344.
33. Boer K, Helinger E, Helinger A, Pocza P, Pos Z, Demeter P, Baranyai Z, Dede K, Darvas Z, Falus A (2008) Decreased expression of histamine H1 and H4 receptors suggests disturbance of local regulation in human colorectal tumours by histamine. Eur J Cell Biol 87(4): 227-236. doi: 10. 1016/j. ejcb. 2007. 12. 003.
34. Cricco G, Martin G, Medina V, Nunez M, Gutierrez A, Cocca C, Bergoc R, Rivera E (2004) Histamine regulates the MAPK pathway via the H(2) receptor in PANC-1 human cells. Inflamm Res 53(Suppl 1): S65-66. doi: 10. 1007/s00011-003-0331-4.
35. Ruffell B, Coussens LM (2011) Histamine restricts cancer: nothing to sneeze at. Nat Med 17(1): 43-44. doi: 10. 1038/nm0111-43.
36. Cianchi F, Vinci MC, Masini E (2008) Histamine in cancer: the dual faces of the coin. Cancer Biol Ther 7(1): 36-37.